Academic Achievements
Patents
Selected Papers
- Xu B#,*, Zhou X, Shan Y, Shi S, Li J, Liang Q, Wang Z, Zhang M, Wang Y, Pei D, Ye S. Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2. EMBO Rep. 2025 Dec 11. doi: 10.1038/s44319-025-00661-9.
- Dong B, Li J, Zhang L, Zhang B, Xu B*, Ye S*, Wang Y*. Structural and functional characterization of thermostable dUTPase P45 from Pyrococcus furiosus with enhanced PCR efficiency. Int J Biol Macromol. 2025 Jul 16:146110.
- Wang Y#, Liang Q#, Liang S#, Shan Y#, Shi S#, Zhou X, Wang Z, Xu Z, Pei D, Zhang M*, Lou Z*, Xu B*, Ye S*. Bardoxolone methyl blocks the efflux of Zn2+ by targeting hZnT1 to inhibit the proliferation and metastasis of cervical cancer. Protein Cell. 2025 Jun 5:pwaf044.
- Shi S#, Li JC#, Zhou XY#, Li ZL*, Wang YX*, Xu BH*, Ye S*. Transport mechanism and drug discovery of human monocarboxylate transporter 1. Acta Pharmacol Sin. 2025 Mar 17.
- Liang Q, Shi S, Zhang Q, Wang Y*, Ye S*, Xu B*. Etoposide targets 2A protease to inhibit enterovirus 71 replication. Microbiol Spectr. 2025 Jan 7;13(1):e0220024.
MOBILE Version